Gene · 2012
Papers1,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| EMP1 correlated with cancer progression and immune characteristics in pan-cancer and ovarian cancer. | Mol Genet Genomics | 2024 | 38743077 | PubTator, text mining | PubMed |
| Cancer-associated fibroblast-derived gene signature discriminates distinct prognoses by integrated single-cell and bulk RNA-seq analyses in breast cancer. | Aging (Albany NY) | 2024 | 38728370 | PubTator, text mining | PubMed |
| Hydrogel-exosome system in tissue engineering: A promising therapeutic strategy. | Bioact Mater | 2024 | 38699243 | PubTator, text mining | PubMed |
| Analysis and prediction of interactions between transmembrane and non-transmembrane proteins. | BMC Genomics | 2024 | 38658824 | PubTator, text mining | PubMed |
| Periodic DFT study of structural transformations of cocrystal CL-20/MMI under high pressure. | J Mol Model | 2024 | 38578379 | PubTator, text mining | PubMed |
| The Transcriptome of BT-20 Breast Cancer Cells Exposed to Curcumin Analog NC2603 Reveals a Relationship between EGR3 Gene Modulation and Cell Migration Inhibition. | Molecules | 2024 | 38543002 | PubTator, text mining | PubMed |
| Identification and Validation of T-Cell Exhaustion Signature for Predicting Prognosis and Immune Response in Pancreatic Cancer by Integrated Analysis of Single-Cell and Bulk RNA Sequencing Data. | Diagnostics (Basel) | 2024 | 38535087 | PubTator, text mining | PubMed |
| Mechanical behaviors of CL-20 under an impact loading: A molecular dynamics study. | J Mol Graph Model | 2024 | 38412812 | PubTator, text mining | PubMed |
| A comprehensive meta-analysis of transcriptome data to identify signature genes associated with pancreatic ductal adenocarcinoma. | PLoS One | 2024 | 38324544 | PubTator, text mining | PubMed |
| Experimental Tumor Induction and Evaluation of Its Treatment in the Chicken Embryo Chorioallantoic Membrane Model: A Systematic Review. | Int J Mol Sci | 2024 | 38255911 | PubTator, text mining | PubMed |
| Inhibitors of Immune Checkpoints: Small Molecule- and Peptide-Based Approaches. | J Pers Med | 2024 | 38248769 | PubTator, text mining | PubMed |
| The Roles of Cystatin B in the Brain and Pathophysiological Mechanisms of Progressive Myoclonic Epilepsy Type 1. | Cells | 2024 | 38247861 | PubTator, text mining | PubMed |
| Pathological phenotypes of astrocytes in Alzheimer's disease. | Exp Mol Med | 2024 | 38172603 | PubTator, text mining | PubMed |
| Role of YAP Signaling in Regulation of Programmed Cell Death and Drug Resistance in Cancer. | Int J Biol Sci | 2024 | 38164167 | PubTator, text mining | PubMed |
| UniTmp: unified resources for transmembrane proteins. | Nucleic Acids Res | 2024 | 37870462 | PubTator, text mining | PubMed |
| Ferroptosis: a potential therapeutic target for stroke. | Neural Regen Res | 2024 | 37862200 | PubTator, text mining | PubMed |
| LMS-Based Pediatric Reference Values for Parameters of Phosphate Homeostasis in the HARP Cohort. | J Clin Endocrinol Metab | 2024 | 37850343 | PubTator, text mining | PubMed |
| Ab initio modeling and ligand docking of quercetin and the MC-LR transporter protein Oatp1b2/OATP1B3. | Pharm Sci Adv | 2023 | 41550783 | PubTator, text mining | PubMed |
| Extracellular vesicles and microvilli in the immune synapse. | Front Immunol | 2023 | 38268920 | PubTator, text mining | PubMed |
| An integrated analysis of bulk and single-cell sequencing data reveals that EMP1+/COL3A1+ fibroblasts contribute to the bone metastasis process in breast, prostate, and renal cancers. | Front Immunol | 2023 | 38187400 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2012/papers?page=7